Home › Companies › Biotechnology, Genetics, Health Care, Medical, Pharmaceutical › Minoryx Therapeutics
Minoryx Therapeutics
Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.
Minoryx Therapeutics is a business in biotechnology, genetics, health care, medical, pharmaceutical based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2011.
The company sits in the biotechnology, genetics, health care, medical, pharmaceutical segment, where it competes on its core product or service.
European Union (EU), Europe, Middle East, and Africa (EMEA) is where the company is located.
Its current recorded stage is Series_C.
The company reports a headcount in the c_00011_00050 range.
Public records show total funding of about $127.3M.
| Sector | Biotechnology, Genetics, Health Care, Medical, Pharmaceutical |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2011 |
| Employees | c_00011_00050 |
| Stage | series_c |
| Total funding | $127,287,500 |
Website: www.minoryx.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account